Friday , July 1 2022

Dengue Virus Diagnostic Tests Market Prospects and Opportunity Assessment Upto 2026


Dengue is a mosquito-borne virus infection disease that affects humans as well as animals. It is caused by the dengue virus belonging to the flaviviridae family and genus flavivirus. Dengue is usually transmitted from one person to another through the bite of an infected aedes aegypti mosquito. Symptoms of this disease are high fever, fatigue, headache, diarrhea, muscle pain, rashes, anemia and vomiting. Serious dengue can cause seizures, yellow skin, coma or death. Dengue causes CNS manifestations, which include abnormal neurological signs, degree of impaired awareness, focal length and generalized cramps and delirium. Causes of neurological manifestations in dengue are due to high quality fever. A number of tests are available on the market to confirm the diagnosis, including detection of antibodies to the virus or its RNA. Management of dengue is a challenge needed to be managed. There are various reasons behind the clinical event of dengue for which multimodal and effective treatment is necessary.

Report Overview @

The global diagnostic test market for dengue virus is expected to increase significantly due to the increased incidence of dengue fever. According to the WHO (World Health Organization), the number of people suffering from dengue increased from 2.2 million in 2010 to 3.2 million in 2015. The actual number remains under reporting. According to data published by Bhatt et al. There are approximately 390 million dengue patients worldwide every year and this number is increasing continuously. 2.35 million dengue patients were single in the Americas region, of which 10,200 patients were detected as serious dengue which resulted in 1,181 deaths in 2015. Dengue is a viral disease affecting people in Europe, South America and Asia. A large number of dengue cases were reported worldwide, with over 111,000 suspected cases of dengue in Malaysia and over 169,000 cases in the Philippines. This was a staggering increase of 16% and 59.5%, respectively, in number of cases compared to 2014. However, low awareness in new countries and high diagnoses limits the market at present. Increased awareness of symptoms of dengue fever and increased government initiatives to provide better care facilities are expected to provide major market opportunities.

Request brochure @

The global dengue virus diagnostic test market can be segmented by type, end user and region. Based on the type, the dengue virus diagnostic test market can be further classified in biomarker analysis, rapid molecular analysis, IsoAmp analysis and others. In the case of end users, the dengue virus diagnostic test market can be classified to hospitals, research institutes and others. Based on region, the dengue virus diagnostic test market can be divided into North America, Europe, Latin America, Asia and Pacific, as well as the Middle East and Africa. Each region is divided into specific countries such as USA, Canada, Germany, USA, Brazil, China, India, Japan and the GCC countries. North America dominated the dengu virus diagnostic test market in 2017. Asia and Latin America are emerging regions in the market. The market in the regions is expected to grow at a rapid pace during the forecast period from 2018 to 2026. Strong expansion in these regions is attributable to the increased presence of dengue, expansion in the healthcare industry and increase of government investment to develop healthcare infrastructure.

Principal players active in the market for dengue virus diagnostic tests are Arkray Inc., Ceres Nanosciences Inc., F. Hoffmann-La Roche Ltd, FK-Biotecnologia SA, Corgenix Medical Corp., QuantuMDx Group Ltd., Quidel Corp., Sansure Biotech Inc., Whidiag SAS, Pictor Ltd. and other prominent players. In order to gain a competitive advantage in the industry, the major players are actively involved in various expansion strategies. Collaborations, partnerships, agreements and new product launches are some of the key strategies that market participants apply.

Source link